查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
人類微生物組市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍：按類型、應用、疾病類型和地理位置
市場調查報告書
商品編碼
1624226

人類微生物組市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍：按類型、應用、疾病類型和地理位置

Human Microbiome Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, Disease Type, and Geography
出版日期: | 出版商: The Insight Partners | 英文 174 Pages | 訂單完成後即時交付

價格

人類微生物組市場預計將從 2023 年的 10.7 億美元增至 2031 年的 48.4 億美元；預計 2023 年至 2031 年市場複合年成長率為 20.8%。推動市場成長的主要因素是主要市場參與者和政府措施的重大投資。此外，精準醫療的出現可能會在預測期內提振市場。然而，商業化過程中的挑戰是市場阻礙因素之一。

人類微生物組產業的成長、創新和市場動態很大程度上受到市場主要參與者的投資影響。主要參與者都在研發方面進行了大量投資，以創造基於微生物組的新型益生菌、診斷和治療方法。這些支出刺激創新，辨識新菌株、作用模式和醫藥用途。臨床試驗獲得大量資金，這對於證明基於微生物組的產品的有效性和安全性至關重要。微生物組圖譜技術的先驅Kanvas Biosciences 於2023 年6 月宣布獲得1,200 萬美元的Pre-A 輪融資。的發展。這些合作夥伴關係使資源、專業知識和技術進步的共享變得更加容易，從而加快了產品開發速度。例如，全球最大的食品和飲料公司雀巢與頂級 SFI 研究中心 APC Microbiome Ireland 於 2023 年 7 月宣布了一項新的合作。增強人類健康和福祉的產品。據報道，多達 120 家公司正在投資微生物組分析，許多新創公司正在進入該領域。 Flagship Pioneering、Seventure Partners 和 BioGaia 是最活躍的投資者。因此，主要參與者的投資增加可能會推動市場的成長。

比較公司分析根據產品組合（產品滿意度、產品功能和可用性）、近期市場發展（併購、新產品推出和增強、投資和融資、獎勵、協議、合作、和合作夥伴關係、認可和擴張）以及有助於更好決策和了解競爭格局的地理分佈。該報告深入探討了全球人類微生物組市場領先供應商近期的重大發展和創新。主要市場參與者為 MaaT Pharma；輝凌控股有限公司；芬奇治療集團公司； AOBiome 治療公司；塞雷斯治療公司；默克公司；養樂多本社有限公司；瑞必泰克斯；公司； IFF 營養與生物科學；和合成生物製劑公司

人類微生物組市場依類型分為產品、軟體和服務。 2023年，該產品領域在人類微生物組市場中佔據更大佔有率，預計2023-2031年期間複合年成長率將更高。人體微生物組包括人體內部和表面的所有微生物。這些微生物具有用於疾病管理的潛力。微生物組產品在治療嚴重疾病和個人化治療方面顯示出前景。微生物群與神經系統疾病、發炎性疾病和癌症有關。

根據應用，市場分為治療、診斷和研究。到2023 年，治療領域將佔據人類微生物組市場的最大佔有率。性。近年來，基於微生物組的療法，也稱為微生物組調節劑，取得了快速進展。一些有前途的候選人已經透過臨床管道取得進展。例如，2023 年4 月，Ferring Pharmaceuticals 的VOWST 是第一個口服的糞便微生物產品，被批准用於預防18 歲及以上患者在接受抗生素治療復發性感染後艱難梭菌(C. difficile) 感染的複發。

根據疾病類型，人類微生物組市場分為肥胖、糖尿病、自體免疫疾病、癌症、胃腸道疾病等。 2023 年，胃腸道疾病細分市場在人類微生物組市場中佔據最大佔有率。

人類微生物組市場的公司採用了各種有機和無機策略。有機策略主要包括產品發布和產品批准。市場上常見的無機成長策略包括收購、合作和夥伴關係。這些成長策略使市場參與者能夠擴大業務並增強其地理影響力，同時為整體市場成長做出貢獻。此外，收購和合作等策略有助於加強他們的客戶群並擴展他們的產品組合。以下列出了人類微生物組市場主要參與者的一些重大進展。

2024 年 3 月，MaaT Pharma 宣佈在歐洲啟動一項名為 CHRONOS 的回顧性多中心試驗。其目標是為未接受 MaaT013 或任何微生物組干預的患者提供三線療法的公司療效資料。這項研究並未受到監管機構的要求，也不會影響現金預測，因為資金已經到位。

2021 年7 月，Seres Therapeutics, Inc. 和雀巢健康科學簽訂了商業化許可協議，共同將Seres 的用於治療復發性艱難梭菌感染(CDI) 的口腔微生物組治療藥物SER-109 在美國和加拿大商業化。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第 4 章：人類微生物組市場格局

  • 概述
  • PEST分析

第 5 章：人類微生物組市場 - 主要市場動態

  • 人類微生物組市場 - 主要市場動態
  • 市場促進因素
    • 主要市場參與者的重大投資
    • 政府舉措
  • 市場限制
    • 商業化過程中的挑戰
  • 市場機會
    • 研發方面的強勁投資
  • 未來趨勢
    • 精準醫學的出現
  • 促進因素和限制的影響：

第 6 章：人類微生物組市場 - 全球市場分析

  • 人類微生物組市場收入，2021-2031
  • 人類微生物組市場預測分析

第 7 章：人類微生物組市場分析 - 按類型

  • 產品
  • 軟體和服務

第 8 章：人類微生物組市場分析 - 按應用

  • 療法
  • 診斷
  • 研究

第 9 章：人類微生物組市場分析 - 按疾病類型

  • 肥胖
  • 糖尿病
  • 自體免疫疾病
  • 癌症
  • 胃腸道
  • 其他

第 10 章：人類微生物組市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 11 章：競爭格局

  • 概述
  • 人類微生物組市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 12 章：公司簡介

  • MaaT Pharma
  • Ferring Holdings SA
  • AOBiome Therapeutics Inc
  • Finch Therapeutics Group Inc
  • Seres Therapeutics Inc
  • Merck & Co Inc
  • Yakult Honsha Co., Ltd.
  • Rebiotix, Inc.
  • IFF Nutrition & Biosciences
  • Synthetic Biologics, Inc.

第 13 章：附錄

Product Code: TIPBT00002233

The human microbiome market is expected to reach US$ 4.84 billion by 2031 from US$ 1.07 billion in 2023; the market is estimated to register a CAGR of 20.8% during 2023-2031. Major factors driving the market growth significant investments by key market players and government initiatives. Further, the emergence of precision medicine is likely to boost the market during the forecast period. However, challenges during commercialization are among the market deterrents.

The human microbiome industry's growth, innovation, and market dynamics are greatly influenced by the investments made by major players in the market. Major players are engaged in making significant investments in research and development to create novel probiotics, diagnostics, and treatments based on the microbiome. These expenditures stimulate innovation, identifying new strains, modes of action, and medicinal uses. Clinical trials receive a large amount of funding, which is essential for demonstrating the effectiveness and safety of products based on the microbiome. A pioneer in microbiome mapping technology, Kanvas Biosciences, announced a US$ 12 million Pre-Series A funding round in June 2023. The company's proprietary platform technology, which has the potential to transform drug development for illnesses linked to the microbiome, will be further developed with the help of the investment. These partnerships make sharing resources, know-how, and technological advancements easier, speeding up product development. For instance, a new collaboration was announced between the world's largest food and beverage company, Nestle, and a top-tier SFI research center, APC Microbiome Ireland, in July 2023. The collaboration centers on different aspects of the human microbiome and helps develop new products to enhance human health and wellness. As many as 120 companies are reportedly investing in microbiome analysis, and numerous startups are entering this field. Flagship Pioneering, Seventure Partners, and BioGaia are the most active investors. Thus, increase in investments by key players is likely drive the growth of market.

The comparative company analysis evaluates and categorizes the human microbiome market based on product portfolio (product satisfaction, product features, and availability), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the global human microbiome market. The key market players are MaaT Pharma; Ferring Holdings SA; Finch Therapeutics Group Inc; AOBiome Therapeutics Inc.; Seres Therapeutics Inc; Merck & Co Inc; Yakult Honsha Co., Ltd; Rebiotix; Inc; IFF Nutrition & Biosciences; and Synthetic Biologics, Inc.

The human microbiome market, based on type, is segmented into product and software and services. The product segment held a larger share of the human microbiome market in 2023, and it is expected to register a higher CAGR during 2023-2031. The human microbiome includes all microorganisms in and on the human body. These microbes have potential for use in disease management. Microbiome products show promise in treating severe conditions and personalizing therapy. The microbiota has been linked to neurological diseases, inflammatory diseases, and cancer.

Based on application, the market is segmented into therapeutics, diagnostics, and research. The therapeutics segment accounted for the largest share of the human microbiome market in 2023. The significant metabolic potential of gut microbes and their role in maintaining human health is emerging, with new possibilities to utilize them as therapeutic agents for addressing human disorders. In recent years, microbiome-based therapeutics, also known as microbiome modulators, have made rapid advances. Several promising candidates have moved forward through the clinical pipeline. For instance, in April 2023, Ferring Pharmaceuticals' VOWST, the first fecal microbiota product taken orally, was approved for preventing recurrence of Clostridioides difficile (C. difficile) infection in patients 18 years and older, following antibiotic treatment for recurrent infection.

Based on disease type, the human microbiome market is segmented into obesity, diabetes, autoimmune disorders, cancer, GIT disorders, and others. The GIT disorders segment held the largest share of the human microbiome market in 2023.

Various organic and inorganic strategies are adopted by companies operating in the human microbiome market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few of the significant developments by key players in the human microbiome market are listed below.

In March 2024, MaaT Pharma announced the launch of a retrospective multicenter trial called CHRONOS in Europe. Its objective is to provide the Company efficacy data for 3rd-line therapies for patients not receiving MaaT013 or any microbiome intervention. This study was not requested by regulatory authorities and does not impact cash projections as funding has already been secured.

In July 2021, Seres Therapeutics, Inc. and Nestle Health Science entered into commercialization license agreement to jointly commercialize SER-109, Seres' investigational oral microbiome therapeutic for recurrent Clostridioides difficile infection (CDI), in the United States (U.S.) and Canada.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Human Microbiome Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Human Microbiome Market - Key Market Dynamics

  • 5.1 Human Microbiome Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Significant Investments by Key Market Players
    • 5.2.2 Government Initiatives
  • 5.3 Market Restraints
    • 5.3.1 Challenges During Commercialization
  • 5.4 Market Opportunities
    • 5.4.1 Robust Investment in Research and Development
  • 5.5 Future Trends
    • 5.5.1 Emergence of Precision Medicine
  • 5.6 Impact of Drivers and Restraints:

6. Human Microbiome Market - Global Market Analysis

  • 6.1 Human Microbiome Market Revenue (US$ Million), 2021-2031
  • 6.2 Human Microbiome Market Forecast Analysis

7. Human Microbiome Market Analysis - by Type

  • 7.1 Product
    • 7.1.1 Overview
    • 7.1.2 Product: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Software and Services
    • 7.2.1 Overview
    • 7.2.2 Software and Services: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)

8. Human Microbiome Market Analysis - by Application

  • 8.1 Therapeutics
    • 8.1.1 Overview
    • 8.1.2 Therapeutics: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Diagnostics
    • 8.2.1 Overview
    • 8.2.2 Diagnostics: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Research
    • 8.3.1 Overview
    • 8.3.2 Research: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)

9. Human Microbiome Market Analysis - by Disease Type

  • 9.1 Obesity
    • 9.1.1 Overview
    • 9.1.2 Obesity: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Diabetes
    • 9.2.1 Overview
    • 9.2.2 Diabetes: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Autoimmune Disorder
    • 9.3.1 Overview
    • 9.3.2 Autoimmune Disorder: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Cancer
    • 9.4.1 Overview
    • 9.4.2 Cancer: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 GIT
    • 9.5.1 Overview
    • 9.5.2 GIT: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)

10. Human Microbiome Market - Geographical Analysis

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 North America Human Microbiome Market Overview
    • 10.2.2 North America: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.2.3 North America: Human Microbiome Market Breakdown, by Type
      • 10.2.3.1 North America: Human Microbiome Market - Revenue and Forecast Analysis - by Type
    • 10.2.4 North America: Human Microbiome Market Breakdown, by Product
      • 10.2.4.1 North America: Human Microbiome Market - Revenue and Forecast Analysis - by Product
    • 10.2.5 North America: Human Microbiome Market Breakdown, by Application
      • 10.2.5.1 North America: Human Microbiome Market - Revenue and Forecast Analysis - by Application
    • 10.2.6 North America: Human Microbiome Market Breakdown, by Disease Type
      • 10.2.6.1 North America: Human Microbiome Market - Revenue and Forecast Analysis - by Disease Type
    • 10.2.7 North America: Human Microbiome Market - Revenue and Forecast Analysis - by Country
      • 10.2.7.1 North America: Human Microbiome Market - Revenue and Forecast Analysis - by Country
      • 10.2.7.2 United States: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.2.7.2.1 United States: Human Microbiome Market Breakdown, by Type
        • 10.2.7.2.2 United States: Human Microbiome Market Breakdown, by Product
        • 10.2.7.2.3 United States: Human Microbiome Market Breakdown, by Application
        • 10.2.7.2.4 United States: Human Microbiome Market Breakdown, by Disease Type
      • 10.2.7.3 Canada: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.2.7.3.1 Canada: Human Microbiome Market Breakdown, by Type
        • 10.2.7.3.2 Canada: Human Microbiome Market Breakdown, by Product
        • 10.2.7.3.3 Canada: Human Microbiome Market Breakdown, by Application
        • 10.2.7.3.4 Canada: Human Microbiome Market Breakdown, by Disease Type
      • 10.2.7.4 Mexico: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.2.7.4.1 Mexico: Human Microbiome Market Breakdown, by Type
        • 10.2.7.4.2 Mexico: Human Microbiome Market Breakdown, by Product
        • 10.2.7.4.3 Mexico: Human Microbiome Market Breakdown, by Application
        • 10.2.7.4.4 Mexico: Human Microbiome Market Breakdown, by Disease Type
  • 10.3 Europe
    • 10.3.1 Europe Human Microbiome Market Overview
    • 10.3.2 Europe: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.3.3 Europe: Human Microbiome Market Breakdown, by Type
      • 10.3.3.1 Europe: Human Microbiome Market - Revenue and Forecast Analysis - by Type
    • 10.3.4 Europe: Human Microbiome Market Breakdown, by Product
      • 10.3.4.1 Europe: Human Microbiome Market - Revenue and Forecast Analysis - by Product
    • 10.3.5 Europe: Human Microbiome Market Breakdown, by Application
      • 10.3.5.1 Europe: Human Microbiome Market - Revenue and Forecast Analysis - by Application
    • 10.3.6 Europe: Human Microbiome Market Breakdown, by Disease Type
      • 10.3.6.1 Europe: Human Microbiome Market - Revenue and Forecast Analysis - by Disease Type
    • 10.3.7 Europe: Human Microbiome Market - Revenue and Forecast Analysis - by Country
      • 10.3.7.1 Europe: Human Microbiome Market - Revenue and Forecast Analysis - by Country
      • 10.3.7.2 United Kingdom: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.7.2.1 United Kingdom: Human Microbiome Market Breakdown, by Type
        • 10.3.7.2.2 United Kingdom: Human Microbiome Market Breakdown, by Product
        • 10.3.7.2.3 United Kingdom: Human Microbiome Market Breakdown, by Application
        • 10.3.7.2.4 United Kingdom: Human Microbiome Market Breakdown, by Disease Type
      • 10.3.7.3 Germany: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.7.3.1 Germany: Human Microbiome Market Breakdown, by Type
        • 10.3.7.3.2 Germany: Human Microbiome Market Breakdown, by Product
        • 10.3.7.3.3 Germany: Human Microbiome Market Breakdown, by Application
        • 10.3.7.3.4 Germany: Human Microbiome Market Breakdown, by Disease Type
      • 10.3.7.4 France: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.7.4.1 France: Human Microbiome Market Breakdown, by Type
        • 10.3.7.4.2 France: Human Microbiome Market Breakdown, by Product
        • 10.3.7.4.3 France: Human Microbiome Market Breakdown, by Application
        • 10.3.7.4.4 France: Human Microbiome Market Breakdown, by Disease Type
      • 10.3.7.5 Italy: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.7.5.1 Italy: Human Microbiome Market Breakdown, by Type
        • 10.3.7.5.2 Italy: Human Microbiome Market Breakdown, by Product
        • 10.3.7.5.3 Italy: Human Microbiome Market Breakdown, by Application
        • 10.3.7.5.4 Italy: Human Microbiome Market Breakdown, by Disease Type
      • 10.3.7.6 Spain: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.7.6.1 Spain: Human Microbiome Market Breakdown, by Type
        • 10.3.7.6.2 Spain: Human Microbiome Market Breakdown, by Product
        • 10.3.7.6.3 Spain: Human Microbiome Market Breakdown, by Application
        • 10.3.7.6.4 Spain: Human Microbiome Market Breakdown, by Disease Type
      • 10.3.7.7 Rest of Europe: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.7.7.1 Rest of Europe: Human Microbiome Market Breakdown, by Type
        • 10.3.7.7.2 Rest of Europe: Human Microbiome Market Breakdown, by Product
        • 10.3.7.7.3 Rest of Europe: Human Microbiome Market Breakdown, by Application
        • 10.3.7.7.4 Rest of Europe: Human Microbiome Market Breakdown, by Disease Type
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific Human Microbiome Market Overview
    • 10.4.2 Asia Pacific: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.4.3 Asia Pacific: Human Microbiome Market Breakdown, by Type
      • 10.4.3.1 Asia Pacific: Human Microbiome Market - Revenue and Forecast Analysis - by Type
    • 10.4.4 Asia Pacific: Human Microbiome Market Breakdown, by Product
      • 10.4.4.1 Asia Pacific: Human Microbiome Market - Revenue and Forecast Analysis - by Product
    • 10.4.5 Asia Pacific: Human Microbiome Market Breakdown, by Application
      • 10.4.5.1 Asia Pacific: Human Microbiome Market - Revenue and Forecast Analysis - by Application
    • 10.4.6 Asia Pacific: Human Microbiome Market Breakdown, by Disease Type
      • 10.4.6.1 Asia Pacific: Human Microbiome Market - Revenue and Forecast Analysis - by Disease Type
    • 10.4.7 Asia Pacific: Human Microbiome Market - Revenue and Forecast Analysis - by Country
      • 10.4.7.1 Asia Pacific: Human Microbiome Market - Revenue and Forecast Analysis - by Country
      • 10.4.7.2 China: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.7.2.1 China: Human Microbiome Market Breakdown, by Type
        • 10.4.7.2.2 China: Human Microbiome Market Breakdown, by Product
        • 10.4.7.2.3 China: Human Microbiome Market Breakdown, by Application
        • 10.4.7.2.4 China: Human Microbiome Market Breakdown, by Disease Type
      • 10.4.7.3 Japan: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.7.3.1 Japan: Human Microbiome Market Breakdown, by Type
        • 10.4.7.3.2 Japan: Human Microbiome Market Breakdown, by Product
        • 10.4.7.3.3 Japan: Human Microbiome Market Breakdown, by Application
        • 10.4.7.3.4 Japan: Human Microbiome Market Breakdown, by Disease Type
      • 10.4.7.4 India: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.7.4.1 India: Human Microbiome Market Breakdown, by Type
        • 10.4.7.4.2 India: Human Microbiome Market Breakdown, by Product
        • 10.4.7.4.3 India: Human Microbiome Market Breakdown, by Application
        • 10.4.7.4.4 India: Human Microbiome Market Breakdown, by Disease Type
      • 10.4.7.5 Australia: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.7.5.1 Australia: Human Microbiome Market Breakdown, by Type
        • 10.4.7.5.2 Australia: Human Microbiome Market Breakdown, by Product
        • 10.4.7.5.3 Australia: Human Microbiome Market Breakdown, by Application
        • 10.4.7.5.4 Australia: Human Microbiome Market Breakdown, by Disease Type
      • 10.4.7.6 South Korea: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.7.6.1 South Korea: Human Microbiome Market Breakdown, by Type
        • 10.4.7.6.2 South Korea: Human Microbiome Market Breakdown, by Product
        • 10.4.7.6.3 South Korea: Human Microbiome Market Breakdown, by Application
        • 10.4.7.6.4 South Korea: Human Microbiome Market Breakdown, by Disease Type
      • 10.4.7.7 Rest of APAC: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.7.7.1 Rest of APAC: Human Microbiome Market Breakdown, by Type
        • 10.4.7.7.2 Rest of APAC: Human Microbiome Market Breakdown, by Product
        • 10.4.7.7.3 Rest of APAC: Human Microbiome Market Breakdown, by Application
        • 10.4.7.7.4 Rest of APAC: Human Microbiome Market Breakdown, by Disease Type
  • 10.5 Middle East and Africa
    • 10.5.1 Middle East and Africa Human Microbiome Market Overview
    • 10.5.2 Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.5.3 Middle East and Africa: Human Microbiome Market Breakdown, by Type
      • 10.5.3.1 Middle East and Africa: Human Microbiome Market - Revenue and Forecast Analysis - by Type
    • 10.5.4 Middle East and Africa: Human Microbiome Market Breakdown, by Product
      • 10.5.4.1 Middle East and Africa: Human Microbiome Market - Revenue and Forecast Analysis - by Product
    • 10.5.5 Middle East and Africa: Human Microbiome Market Breakdown, by Application
      • 10.5.5.1 Middle East and Africa: Human Microbiome Market - Revenue and Forecast Analysis - by Application
    • 10.5.6 Middle East and Africa: Human Microbiome Market Breakdown, by Disease Type
      • 10.5.6.1 Middle East and Africa: Human Microbiome Market - Revenue and Forecast Analysis - by Disease Type
    • 10.5.7 Middle East and Africa: Human Microbiome Market - Revenue and Forecast Analysis - by Country
      • 10.5.7.1 Middle East and Africa: Human Microbiome Market - Revenue and Forecast Analysis - by Country
      • 10.5.7.2 South Africa: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.7.2.1 South Africa: Human Microbiome Market Breakdown, by Type
        • 10.5.7.2.2 South Africa: Human Microbiome Market Breakdown, by Product
        • 10.5.7.2.3 South Africa: Human Microbiome Market Breakdown, by Application
        • 10.5.7.2.4 South Africa: Human Microbiome Market Breakdown, by Disease Type
      • 10.5.7.3 Saudi Arabia: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.7.3.1 Saudi Arabia: Human Microbiome Market Breakdown, by Type
        • 10.5.7.3.2 Saudi Arabia: Human Microbiome Market Breakdown, by Product
        • 10.5.7.3.3 Saudi Arabia: Human Microbiome Market Breakdown, by Application
        • 10.5.7.3.4 Saudi Arabia: Human Microbiome Market Breakdown, by Disease Type
      • 10.5.7.4 United Arab Emirates: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.7.4.1 United Arab Emirates: Human Microbiome Market Breakdown, by Type
        • 10.5.7.4.2 United Arab Emirates: Human Microbiome Market Breakdown, by Product
        • 10.5.7.4.3 United Arab Emirates: Human Microbiome Market Breakdown, by Application
        • 10.5.7.4.4 United Arab Emirates: Human Microbiome Market Breakdown, by Disease Type
      • 10.5.7.5 Rest of Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.7.5.1 Rest of Middle East and Africa: Human Microbiome Market Breakdown, by Type
        • 10.5.7.5.2 Rest of Middle East and Africa: Human Microbiome Market Breakdown, by Product
        • 10.5.7.5.3 Rest of Middle East and Africa: Human Microbiome Market Breakdown, by Application
        • 10.5.7.5.4 Rest of Middle East and Africa: Human Microbiome Market Breakdown, by Disease Type
  • 10.6 South and Central America
    • 10.6.1 South and Central America Human Microbiome Market Overview
    • 10.6.2 South and Central America: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.6.3 South and Central America: Human Microbiome Market Breakdown, by Type
      • 10.6.3.1 South and Central America: Human Microbiome Market - Revenue and Forecast Analysis - by Type
    • 10.6.4 South and Central America: Human Microbiome Market Breakdown, by Product
      • 10.6.4.1 South and Central America: Human Microbiome Market - Revenue and Forecast Analysis - by Product
    • 10.6.5 South and Central America: Human Microbiome Market Breakdown, by Application
      • 10.6.5.1 South and Central America: Human Microbiome Market - Revenue and Forecast Analysis - by Application
    • 10.6.6 South and Central America: Human Microbiome Market Breakdown, by Disease Type
      • 10.6.6.1 South and Central America: Human Microbiome Market - Revenue and Forecast Analysis - by Disease Type
    • 10.6.7 South and Central America: Human Microbiome Market - Revenue and Forecast Analysis - by Country
      • 10.6.7.1 South and Central America: Human Microbiome Market - Revenue and Forecast Analysis - by Country
      • 10.6.7.2 Brazil: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.6.7.2.1 Brazil: Human Microbiome Market Breakdown, by Type
        • 10.6.7.2.2 Brazil: Human Microbiome Market Breakdown, by Product
        • 10.6.7.2.3 Brazil: Human Microbiome Market Breakdown, by Application
        • 10.6.7.2.4 Brazil: Human Microbiome Market Breakdown, by Disease Type
      • 10.6.7.3 Argentina: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.6.7.3.1 Argentina: Human Microbiome Market Breakdown, by Type
        • 10.6.7.3.2 Argentina: Human Microbiome Market Breakdown, by Product
        • 10.6.7.3.3 Argentina: Human Microbiome Market Breakdown, by Application
        • 10.6.7.3.4 Argentina: Human Microbiome Market Breakdown, by Disease Type
      • 10.6.7.4 Rest of South and Central America: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.6.7.4.1 Rest of South and Central America: Human Microbiome Market Breakdown, by Type
        • 10.6.7.4.2 Rest of South and Central America: Human Microbiome Market Breakdown, by Product
        • 10.6.7.4.3 Rest of South and Central America: Human Microbiome Market Breakdown, by Application
        • 10.6.7.4.4 Rest of South and Central America: Human Microbiome Market Breakdown, by Disease Type

11. Competitive Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Human Microbiome Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 MaaT Pharma
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Ferring Holdings SA
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 AOBiome Therapeutics Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Finch Therapeutics Group Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Financial Overview
    • 12.4.4 SWOT Analysis
    • 12.4.5 Key Developments
  • 12.5 Seres Therapeutics Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Merck & Co Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Yakult Honsha Co., Ltd.
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Rebiotix, Inc.
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 IFF Nutrition & Biosciences
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Synthetic Biologics, Inc.
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 Glossary of Terms
  • 13.2 About The Insight Partners

List Of Tables

  • Table 1. Human Microbiome Market Segmentation
  • Table 2. Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 4. Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million) - by Product
  • Table 5. Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 6. Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million) - by Disease Type
  • Table 7. North America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 8. North America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 9. North America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 10. North America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 11. North America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 12. United States: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 13. United States: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 14. United States: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 15. United States: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 16. Canada: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 17. Canada: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 18. Canada: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 19. Canada: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 20. Mexico: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 21. Mexico: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 22. Mexico: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 23. Mexico: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 24. Europe: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 25. Europe: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 26. Europe: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 27. Europe: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 28. Europe: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 29. United Kingdom: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 30. United Kingdom: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 31. United Kingdom: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 32. United Kingdom: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 33. Germany: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 34. Germany: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 35. Germany: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 36. Germany: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 37. France: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 38. France: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 39. France: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 40. France: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 41. Italy: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 42. Italy: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 43. Italy: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 44. Italy: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 45. ADULT OBESITY, 2030
  • Table 46. CHILD OBESITY, 2030
  • Table 47. Spain: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 48. Spain: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 49. Spain: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 50. Spain: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 51. Rest of Europe: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 52. Rest of Europe: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 53. Rest of Europe: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 54. Rest of Europe: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 55. Asia Pacific: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 56. Asia Pacific: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 57. Asia Pacific: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 58. Asia Pacific: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 59. Asia Pacific: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 60. China: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 61. China: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 62. China: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 63. China: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 64. Japan: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 65. Japan: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 66. Japan: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 67. Japan: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 68. India: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 69. India: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 70. India: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 71. India: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 72. Australia: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 73. Australia: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 74. Australia: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 75. Australia: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 76. South Korea: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 77. South Korea: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 78. South Korea: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 79. South Korea: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 80. Rest of APAC: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 81. Rest of APAC: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 82. Rest of APAC: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 83. Rest of APAC: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 84. Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 85. Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 86. Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 87. Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 88. Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 89. South Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 90. South Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 91. South Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 92. South Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 93. Saudi Arabia: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 94. Saudi Arabia: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 95. Saudi Arabia: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 96. Saudi Arabia: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 97. United Arab Emirates: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 98. United Arab Emirates: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 99. United Arab Emirates: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 100. United Arab Emirates: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 101. Rest of Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 102. Rest of Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 103. Rest of Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 104. Rest of Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 105. South and Central America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 106. South and Central America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 107. South and Central America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 108. South and Central America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 109. South and Central America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 110. Brazil: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 111. Brazil: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 112. Brazil: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 113. Brazil: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 114. Argentina: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 115. Argentina: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 116. Argentina: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 117. Argentina: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 118. Rest of South and Central America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 119. Rest of South and Central America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Product
  • Table 120. Rest of South and Central America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 121. Rest of South and Central America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million) - by Disease Type
  • Table 122. Recent Organic Growth Strategies in the Human Microbiome Market
  • Table 123. Recent Inorganic Growth Strategies in the Human Microbiome Market
  • Table 124. Glossary of Terms, Microelectrode Array in Vitro Market

List Of Figures

  • Figure 1. Human Microbiome Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Human Microbiome Market Revenue (US$ Million), 2021-2031
  • Figure 5. Human Microbiome Market Share (%) - by Type (2023 and 2031)
  • Figure 6. Product: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Software and Services: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Human Microbiome Market Share (%) - by Application (2023 and 2031)
  • Figure 9. Therapeutics: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Diagnostics: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Research: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Human Microbiome Market Share (%) - by Disease Type (2023 and 2031)
  • Figure 13. Obesity: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Diabetes: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Autoimmune Disorder: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Cancer: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. GIT: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Others: Human Microbiome Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Human Microbiome Market Breakdown by Region, 2023 and 2031 (%)
  • Figure 20. North America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 21. North America: Human Microbiome Market Breakdown, by Type (2023 and 2031)
  • Figure 22. North America: Human Microbiome Market Breakdown, by Product (2023 and 2031)
  • Figure 23. North America: Human Microbiome Market Breakdown, by Application (2023 and 2031)
  • Figure 24. North America: Human Microbiome Market Breakdown, by Disease Type (2023 and 2031)
  • Figure 25. North America: Human Microbiome Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 26. United States: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 27. Canada: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 28. Mexico: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 29. Europe: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 30. Europe: Human Microbiome Market Breakdown, by Type (2023 and 2031)
  • Figure 31. Europe: Human Microbiome Market Breakdown, by Product (2023 and 2031)
  • Figure 32. Europe: Human Microbiome Market Breakdown, by Application (2023 and 2031)
  • Figure 33. Europe: Human Microbiome Market Breakdown, by Disease Type (2023 and 2031)
  • Figure 34. Europe: Human Microbiome Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 35. United Kingdom: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 36. Germany: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 37. France: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 38. Italy: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 39. Spain: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 40. Rest of Europe: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 41. Asia Pacific: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 42. Asia Pacific: Human Microbiome Market Breakdown, by Type (2023 and 2031)
  • Figure 43. Asia Pacific: Human Microbiome Market Breakdown, by Product (2023 and 2031)
  • Figure 44. Asia Pacific: Human Microbiome Market Breakdown, by Application (2023 and 2031)
  • Figure 45. Asia Pacific: Human Microbiome Market Breakdown, by Disease Type (2023 and 2031)
  • Figure 46. Asia Pacific: Human Microbiome Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 47. China: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 48. Japan: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 49. India: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 50. Australia: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 51. South Korea: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 52. Rest of APAC: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 53. Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 54. Middle East and Africa: Human Microbiome Market Breakdown, by Type (2023 and 2031)
  • Figure 55. Middle East and Africa: Human Microbiome Market Breakdown, by Product (2023 and 2031)
  • Figure 56. Middle East and Africa: Human Microbiome Market Breakdown, by Application (2023 and 2031)
  • Figure 57. Middle East and Africa: Human Microbiome Market Breakdown, by Disease Type (2023 and 2031)
  • Figure 58. Middle East and Africa: Human Microbiome Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 59. South Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 60. Saudi Arabia: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 61. United Arab Emirates: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 62. Rest of Middle East and Africa: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 63. South and Central America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 64. South and Central America: Human Microbiome Market Breakdown, by Type (2023 and 2031)
  • Figure 65. South and Central America: Human Microbiome Market Breakdown, by Product (2023 and 2031)
  • Figure 66. South and Central America: Human Microbiome Market Breakdown, by Application (2023 and 2031)
  • Figure 67. South and Central America: Human Microbiome Market Breakdown, by Disease Type (2023 and 2031)
  • Figure 68. South and Central America: Human Microbiome Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 69. Brazil: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 70. Argentina: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 71. Rest of South and Central America: Human Microbiome Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 72. Growth Strategies in the Human Microbiome Market